ArticlePloS one2025
Association between the ferritin level and risk of gestational diabetes mellitus: A prospective cohort study.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- First-trimester ferritin levels and gestational diabetes mellitus risk in twin pregnancies: a retrospective cohort study.BMC pregnancy and childbirth · 2026Article
- Editorial: Recent advances in gestational diabetes: diagnosis, treatment and prevention.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveIron is increasingly recognized to influence glucose metabolism. However, evidence about the linkage between body iron stores and the risk of developing gestational diabetes mellitus (GDM) is still inconclusive. We aimed to prospectively investigate the association of serum ferritin concentrations with GDM.
methodsWe studied 847 women from Peking University International Hospital from December 2017 to March 2019. Serum ferritin concentrations were measured three times during pregnancy (gestational weeks 6-12, 24-28 and 32-34). GDM was diagnosed by a 75-g oral-glucose-tolerance test (OGTT) at 24-28 weeks' gestation. Logistic regression analyses were carried out to determine the influence of serum ferritin at the first and second trimester on the risk of developing GDM.
resultsAmong 847 participants, 73 women (8.6%) developed GDM. The median (IQR) of serum ferritin concentrations were 50.6 (32.4-75.5) ng/mL at gestational weeks 6-12, 19.7 (12.0-28.4) ng/mL at gestational weeks 24-28 and 19.4 (11.4-27.2) ng/mL at gestational weeks 32-34. The median serum ferritin concentrations were all significantly higher in women with GDM than those without GDM at the first, second and third trimester. Ferritin concentrations were positively correlated with the risk of GDM; the adjusted OR (95% CI) for highest vs lowest quartile was 2.97 (1.36, 6.51) at the first trimester and 2.64 (1.26, 5.54) at the second trimester.
conclusionsElevated serum ferritin concentrations in the first and second trimester during pregnancy are both independently associated with increased risk of GDM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.